Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00910013

Femoral Block With or Without Ropivacaine for Analgesia After Total Knee Replacement (TKR) (TKR)

A Randomized Trial Comparing the Efficacy on Post-operative Analgesia of Intra-articular Ropivacaine Added to a Femoral Block After Total Knee Replacement

Sponsor: Hopital de l'Enfant-Jesus

Conditions Total Knee Replacement

Interventions Ropivacaine

Updated 5 times since 2017 Last updated: Feb 25, 2011 Started: Apr 30, 2006 Primary completion: Mar 31, 2008 Completion: Mar 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00910013, this PHASE1/PHASE2 trial focuses on Total Knee Replacement and remains completed. Sponsored by Hopital de l'Enfant-Jesus, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hopital de l'Enfant-Jesus

Data source: Hopital de l'Enfant-Jesus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Québec, Canada